Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration

Renal Failure

Volumn 30, Issue 9, 2008, Pages 861-864

  Christidou, Fotini ^a   Bamichas, Gerasimos ^a   Galaktidou, Grammate ^b   Fragidis, Stylianos ^a   Gionanlis, Lazaros ^a   Frangia, Theodora ^a   Bischiniotis, Theodoros ^b   Sombolos, Kostas ^a,c  

^a Nephrology Department GH G Papanikolaou   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

Hemodialysis; Hepatocyte growth factor; HGF; LMWH

Indexed keywords

HEPARIN; SCATTER FACTOR; SODIUM CHLORIDE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MALE; PRIORITY JOURNAL; ULTRAFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS;

EID: 54249105820     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220802353835     Document Type: Article

References (15)

1. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor from hepatopoiesis to hematopoiesis. J Cell Biol. 1995;129:1177-1180.
2. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met protooncogene product. Science. 1991;251:802-804.
3. Randers E, Erlandsen EJ, Kristensen JH, et al. Serum hepatocyte growth factor levels in patients with chronic renal disease-effect of GFR and pathogenesis. Scand J Clin Lab Invest. 2001;61(8):615-619.
4. Rampino T, Libetta C, De Simone W, et al. Hemodialysis stimulates hepatocyte growth factor release. Kidney Int. 1998;53:1382-1388.
5. Naka D, Ishii T, Shimomura T, et al. Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes. Exp Cell Res. 1993;209:317-324.
6. Taniguchi T, Toi M, Tonimaga T. Rapid induction of hepatocyte growth factor by heparin. Lancet. 1994;344:470.
7. Rampino T, Cancarini G, Gregorini M, et al. Hepatocyte growth factor/scatter factor released during peritonitis is active on mesothelial cells. Am J Pathology. 2001;159:1275-1285.
8. Lohr JW, Lee TP, Farooqui M, Mookerjee BK. Increased levels of serum hepatocyte growth factor in patients with end stage renal disease. J Med. 2001;31:131-141.
9. Sugimura K, Kim T, Goto T, et al. Serum hepatocyte growth factor levels in patients with chronic renal failure. Nephron. 1995;70:324-328.
10. Bilezikci B, Demirhan B, Ozdemir N, Elsurer R. Expression of hepatocyte growth factor in chronic hepatitis: effect of hemodialysis. Ren Fail. 2006;28:557-560.
11. Memoli B, Libetta C, Rampino T, et al. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int. 1992;42:320-326.
12. Borawski J, Naumnik B, Mysliwiec M. Striking increase in circulating hepatocyte growth factor during enoxaparin-anticoagulated haemodialysis. Nephrol Dial Transplant. 2003;18:1680-1682.
13. Matsumori A, Ono K, Okada M, et al. Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin. J Mol Cell Cardiol. 1998;30:2145-2149.
14. Seidel C, Bendz B, et al. Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals. Br J Hematol. 1999;105:641-647.
15. Borawski J, Mysliwiec M. Serum hepatocyte growth factor is associated with viral hepatitis, cardiovascular disease, erythropoietin treatment, and type of heparin in haemodialysis patients. Nephrol Dial Transplant. 2002;17:637-644.